Ph.D., Specialist of GIST tumor biology.
Olli-Pekka Pulkka, Ph.D. (born in 1985) is a founder and board member of the Company. He is a cell and molecular biologist with a PhD from the University of Helsinki, Finland in 2019. His research is focused on the prognostic factors and novel therapeutic targets in GIST. Dr. Pulkka prepared his PhD thesis on the role of PDE3 as a therapy target in GIST.